MedPath

TYSABRI 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION

TYSABRI 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

06346001

Prescription Type

Uso Hospitalario

Authorization Date

Sep 25, 2006

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number06346001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

NATALIZUMABActive
Quantity: 20 mg
Name: NATALIZUMAB

ATC CLASSIFICATION (3)

L04A
L04AG
L04AG03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.